TY - JOUR
T1 - Predictors of Treatment Failure After 2-Stage Reimplantation for Infected Total Knee Arthroplasty
T2 - A 2- to 10-Year Follow-Up
AU - Ma, Chen Yang
AU - Lu, Yu Der
AU - Bell, Kerri L.
AU - Wang, Jun Wen
AU - Ko, Jih Yang
AU - Wang, Ching Jen
AU - Kuo, Feng Chih
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/7
Y1 - 2018/7
N2 - Background: The aim of this study is to identify risk factors which may lead to treatment failure following 2-stage reimplantation for chronic infected total knee arthroplasty (TKA). Methods: We retrospectively reviewed 106 patients (108 knees) who underwent consecutive 2-stage revision for chronic PJI of the knee at our institution between January 2005 and December 2015. A total of 31 risk factors, including patient characteristics, comorbidities, surgical variables, and microbiology data, were collected. Kaplan-Meier survival and Cox regression analyses were used to calculate survival rates and adjusted hazard ratios (HRs) of treatment failure. Results: Within the cohort, 16 of the 108 2-stage reimplantations (14.8%) had treatment failure. The treatment success for 2-stage reimplantation was 91% (95% confidence interval [CI] 0.8-1.0) at 2 years and 84% (95% CI 0.8-0.9) at 5 and 10 years. Multivariate analysis provided the strongest predictors of treatment failure, including body mass index ≥30 kg/m2 (adjusted HR 9.3, 95% CI 2.7-31.8, P <.001), operative time >4 hours (adjusted HR 11.3, 95% CI 3.9-33.1, P <.001), gout (adjusted HR 13.8, 95% CI 2.9-66.1, P =.001), and the presence of Enterococcus species during resection arthroplasty (adjusted HR 14.1, 95% CI 2.6-76.3, P =.002). Conclusion: Our study identified 4 potential risk factors that may predict treatment failure following 2-stage revision for chronic knee PJI. This finding may be useful when counseling patients regarding the treatment success and prognosis of 2-stage reimplantation for infected TKA.
AB - Background: The aim of this study is to identify risk factors which may lead to treatment failure following 2-stage reimplantation for chronic infected total knee arthroplasty (TKA). Methods: We retrospectively reviewed 106 patients (108 knees) who underwent consecutive 2-stage revision for chronic PJI of the knee at our institution between January 2005 and December 2015. A total of 31 risk factors, including patient characteristics, comorbidities, surgical variables, and microbiology data, were collected. Kaplan-Meier survival and Cox regression analyses were used to calculate survival rates and adjusted hazard ratios (HRs) of treatment failure. Results: Within the cohort, 16 of the 108 2-stage reimplantations (14.8%) had treatment failure. The treatment success for 2-stage reimplantation was 91% (95% confidence interval [CI] 0.8-1.0) at 2 years and 84% (95% CI 0.8-0.9) at 5 and 10 years. Multivariate analysis provided the strongest predictors of treatment failure, including body mass index ≥30 kg/m2 (adjusted HR 9.3, 95% CI 2.7-31.8, P <.001), operative time >4 hours (adjusted HR 11.3, 95% CI 3.9-33.1, P <.001), gout (adjusted HR 13.8, 95% CI 2.9-66.1, P =.001), and the presence of Enterococcus species during resection arthroplasty (adjusted HR 14.1, 95% CI 2.6-76.3, P =.002). Conclusion: Our study identified 4 potential risk factors that may predict treatment failure following 2-stage revision for chronic knee PJI. This finding may be useful when counseling patients regarding the treatment success and prognosis of 2-stage reimplantation for infected TKA.
KW - periprosthetic joint infection
KW - revision knee
KW - risk factor
KW - treatment failure
KW - two stage
UR - http://www.scopus.com/inward/record.url?scp=85044156584&partnerID=8YFLogxK
U2 - 10.1016/j.arth.2018.02.007
DO - 10.1016/j.arth.2018.02.007
M3 - 文章
C2 - 29572036
AN - SCOPUS:85044156584
SN - 0883-5403
VL - 33
SP - 2234
EP - 2239
JO - Journal of Arthroplasty
JF - Journal of Arthroplasty
IS - 7
ER -